Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara J Thomas

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Developmental Cell|April 6, 2005
Cell-cycle control during development: taking it up a notchBarbara J Thomas
Developmental Biology|August 11, 2007
Mutation of the Apc1 homologue shattered disrupts normal eye development by disrupting G1 cell cycle arrest and progression through mitosisMiho Tanaka-Matakatsu, Barbara J Thomas, Wei Du
Frontiers in Endocrinology|September 7, 2021
Update on Targeted Therapy in Medullary Thyroid CancerChristian Okafor, Julie Hogan, Margarita Raygada, et al.
Pediatric Blood & Cancer|June 22, 2023
NCI intramural program approach to rare tumors: Natural history study of rare solid tumors in children and adults: A longitudinal, comprehensive data and biospecimen collection protocolMary Frances Wedekind, Karlyne M Reilly, Jaydira Del Rivero, et al.
The Journal of Clinical Endocrinology and Metabolism|September 3, 2022
Fracture Risk in Pediatric Patients With MEN2BIris Li, Iris R Hartley, Joanna Klubo-Gwiedzdzinska, et al.
Pediatric Blood & Cancer|June 22, 2023
The NIH pediatric/young adult chordoma clinic and natural history study: Making advances in a very rare tumorLiny John, Hannah Smith, Maran Ilanchezhian, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Developmental Cell|April 6, 2005
Cell-cycle control during development: taking it up a notchBarbara J Thomas
Developmental Biology|August 11, 2007
Mutation of the Apc1 homologue shattered disrupts normal eye development by disrupting G1 cell cycle arrest and progression through mitosisMiho Tanaka-Matakatsu, Barbara J Thomas, Wei Du
Frontiers in Endocrinology|September 7, 2021
Update on Targeted Therapy in Medullary Thyroid CancerChristian Okafor, Julie Hogan, Margarita Raygada, et al.
Pediatric Blood & Cancer|June 22, 2023
NCI intramural program approach to rare tumors: Natural history study of rare solid tumors in children and adults: A longitudinal, comprehensive data and biospecimen collection protocolMary Frances Wedekind, Karlyne M Reilly, Jaydira Del Rivero, et al.
The Journal of Clinical Endocrinology and Metabolism|September 3, 2022
Fracture Risk in Pediatric Patients With MEN2BIris Li, Iris R Hartley, Joanna Klubo-Gwiedzdzinska, et al.
Pediatric Blood & Cancer|June 22, 2023
The NIH pediatric/young adult chordoma clinic and natural history study: Making advances in a very rare tumorLiny John, Hannah Smith, Maran Ilanchezhian, et al.
Pageof 1